Body

Experimental graft-vs.-host disease treatment equivalent to standard care in Phase 3 trial

An experimental drug combination for preventing graft-versus-host disease (GVHD) was not significantly better than the standard regimen on key endpoints, according to a report of a phase 3 trial at the American Society of Hematology annual meeting.

The combination of two immunosuppressive compounds -- tacrolimus plus sirolimus -- did not provide a statistically significant, GVHD-free survival benefit over the long-used standard of care, tacrolimus plus methotrexate, said researchers from Dana-Farber Cancer Institute who led the multi-center trial.

Binge eating, overeating may be associated with initiating use of marijuana, other drugs

CHICAGO – Overeating and binge eating may be associated with initiating use of marijuana and other drugs in a study of adolescents and young adults, according to a study published Online First by Archives of Pediatrics & Adolescent Medicine, a JAMA Network publication.

Study suggests odds of visual field testing for glaucoma decreased most for Hispanics in past decade

CHICAGO – The odds of individuals with open-angle glaucoma undergoing visual field testing decreased for all racial/ethnic groups from 2001 through 2009, but the odds decreased the most for Hispanic men and women in a study of enrollees in a large U.S. managed care network, according to a report published in the December issue of Archives of Ophthalmology, a JAMA Network publication.

Diabetes prevention program interventions lead to reduced BMI over usual care

CHICAGO – Two adapted diabetes lifestyle interventions resulted in weight loss, as well as improvements in waist circumference and fasting plasma glucose level, for overweight or obese adults compared with usual care over a 15-month period, according to a report of a randomized trial published Online First by Archives of Internal Medicine, a JAMA Network publication.

Point-of-care ultrasound is more accurate than the stethoscope in diagnosing pneumonia in children

Point-of-care ultrasound is more accurate than the traditional method of auscultation by stethoscope in diagnosing pneumonia in children and young adults, and can even detect small pneumonias that a chest x-ray may miss, a Mount Sinai researcher reports in an article titled, "Prospective Evaluation of Point-of-Care Ultrasonography for the Diagnosis of Pneumonia in Children and Young Adults" in the online edition of Archives of Pediatrics & Adolescent Medicine published December 10, 2012.

Blood levels of immune protein predict risk in Hodgkin disease

Blood levels of an immunity-related protein, galectin-1, in patients with newly diagnosed Hodgkin lymphoma reflected the extent of their cancer and correlated with other predictors of outcome, scientists reported at the American Society of Hematology annual meeting.

In a study of 315 patients from a German database, researchers from Dana-Farber Cancer Institute found that serum galectin-1 levels "are significantly associated with tumor burden and additional adverse clinical characteristics in newly diagnosed Hodgkin lymphoma (HL) patients."

Wayne State researcher finds possible clue to children's early antisocial behavior

DETROIT - Both nature and nurture appear to be significant factors in early antisocial behaviors of adopted children, a Wayne State University researcher believes.

Christopher Trentacosta, Ph.D., assistant professor of psychology in the College of Liberal Arts and Sciences, recently examined data from 361 linked triads (birth mother, adoptive parents, adopted child) in order to assess externalizing behavioral problems such as aggression and defiance when children were 18, 27 and 54 months of age.

Asteroid that killed the dinosaurs also wiped out the 'Obamadon'

New Haven, Conn. — The asteroid collision widely thought to have killed the dinosaurs also led to extreme devastation among snake and lizard species, according to new research — including the extinction of a newly identified lizard species Yale and Harvard scientists have named Obamadon gracilis.

Biologists engineer algae to make complex anti-cancer 'designer' drug

Biologists at UC San Diego have succeeded in genetically engineering algae to produce a complex and expensive human therapeutic drug used to treat cancer.

Their achievement, detailed in a paper in this week's early online issue of The Proceedings of the National Academy of Sciences, opens the door for making these and other "designer" proteins in larger quantities and much more cheaply than can now be made from mammalian cells.

Inspiration from a porcupine's quills

CAMBRIDGE, MA -- Anyone unfortunate enough to encounter a porcupine's quills knows that once they go in, they are extremely difficult to remove. Researchers at MIT and Brigham and Women's Hospital now hope to exploit the porcupine quill's unique properties to develop new types of adhesives, needles and other medical devices.

Mayo Clinic researchers uncover toxic interaction in neurons that leads to dementia and ALS

JACKSONVILLE, Fla. — Researchers at Mayo Clinic in Florida have uncovered a toxic cellular process by which a protein that maintains the health of neurons becomes deficient and can lead to dementia.

Pharmacy researcher finds most popular weight-loss drug strongly alters other drug therapies

KINGSTON, R.I.— December 10, 2012 – A University of Rhode Island researcher has discovered that the weight-loss drug orlistat, known by the brand names Xenical and Alli, inhibits a key enzyme that may lead to "severe toxicity of internal organs such as the liver and kidney." The inhibition is irreversible and can be caused by a low level of the drug.

Professor Bingfang Yan's study funded by the National Institutes of Health, also found that the drug alters efficacy of medicines, and particularly limits the effectiveness of some anti-cancer drugs.

Novel drug therapy targets aggressive form of non-Hodgkin's lymphoma

NEW YORK (Dec. 10, 2012) -- Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin's lymphoma and the seventh most frequently diagnosed cancer. The most chemotherapy resistant form of DLBCL, called activated B-cell – DLBCL (ABC-DLBCL), remains a major therapeutic challenge. An international research team, led by two laboratories from Weill Cornell Medical College, has developed a new experimental drug therapy to target this aggressive form of lymphoma.

Infants with severe RSV disease may be immunosuppressed

Infants with severe lower respiratory tract infection caused by respiratory syncytial virus (RSV) may have a dysfunctional innate immune response that relates to the severity of their disease. These are the findings from a Nationwide Children's Hospital study appearing in a recent issue of the Journal of Infectious Diseases.

Caffeinated coffee may reduce the risk of oral cancers

ATLANTA – December 10, 2012—A new American Cancer Society study finds a strong inverse association between caffeinated coffee intake and oral/pharyngeal cancer mortality. The authors say people who drank more than four cups of caffeinated coffee per day were at about half the risk of death of these often fatal cancers compared to those who only occasionally or who never drank coffee. The study is published online in the American Journal of Epidemiology. The authors say more research is needed to elucidate the biologic mechanisms that could be at work.